1st line treatment for all patients: methylphenidate
Xaggitin XL is the GGC formulary preferred formulation.
2nd line treatment for all patients: atomoxetine, guanfacine or lisdexamfetamine
1st line treatment for all patients: methylphenidate
Xaggitin XL is the GGC formulary preferred formulation.
2nd line treatment for all patients: atomoxetine, guanfacine or lisdexamfetamine
Blood pressure & pulse: Baseline, before and after dose changes, once stable 6 monthly.
Weight: 6 monthly
Height: 6 monthly for children and adolescents with growth chart completion.
Mental health status: Assess for development or deterioration of pre-existing conditions at each dose change, at each visit and 6 monthly.
ECG: Baseline and after dose changes are only necessary in patients with a history of congenital prolonged QTc syndrome or previous drug induced prolonged QTc.
Choice and medication offers a wide range of patient information leaflets for mental health conditions and the medication used to treat them.
Crisis Counselling (counselling service that works with people to achieve better mental health)
Cruse Scotland (bereavement support)
The Spark - Igniting Change (charity that provides counselling and mental health support services)